Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified antiplatelet therapy after Firehawk stent implantation in acute myocardial infarction
NL-OMON59710Phase 4Completed
- Sponsor
- MicroPort EverPace
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel in myocardial infarction (MI) (2 arms), sponsored by MicroPort EverPace. Started Jun 2021; status: completed.
02
Drugs
prasugrel
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON59710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59710.